Deal Watch: Success Nets CytomX Another $200m From BMS, Up To $3.6bn For Milestones

 
• By Mandy Jackson, Ian Haydock, Anju Ghangurde, and Joseph Haas
  
DealWatch_1200x675

More from Business

More from Scrip